Israel’s Biond Biologics (see here previously) has begun multi-center trials of BND-35. It is already trialing BND-22. Both are immunotherapy treatments for solid tumors.

https://nocamels.com/2024/06/novel-cancer-immunotherapy-drug-given-to-first-patient-in-trial/

https://www.biondbio.com/clinical-trials/

https://www.clinicaltrials.gov/study/NCT06274437?term=BND-35&rank=1

https://www.clinicaltrials.gov/study/NCT04717375?term=BND-22&rank=1